Research shows that about 80% of women in the United States — about 29 million each year — experience vasomotor symptoms (VMS), otherwise known as hot flashes, with an average duration during menopause of about 10 years. Yet, women’s health at midlife has been largely overlooked due to prevailing stigmas, lack of understanding and limited guidance. Astellas is working to debunk the stigmas around menopause by engaging with many stakeholders on public policies that provide support to women’s health at midlife.
In honor of Women’s Health Month, I sat down with Christie Bloomquist, Vice President of Government Affairs and Policy at Astellas, to discuss their work to support women experiencing menopause. Learn how the momentum is building to meaningfully address women’s health care needs during this stage of life in the video below.
Elizabeth Carpenter
Elizabeth Carpenter serves as executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA).
Carpenter leads policy and research at PhRMA, focusing on policy analysis, original research and policy development. Previously, she spent 10 years at the health policy and business strategy firm, Avalere, most recently serving as president. Prior to joining Avalere, Carpenter was a senior advisor in the health policy practice at McKenna Long & Aldridge LLP, where she provided government affairs and public policy support to payers, providers, private exchanges, and states on a wide range of health policy and political issues.
Previously, she served as the associate policy director for the Health Policy Program at the New America Foundation where she led Congressional and media relations during the debate over the ACA and provided educational and technical support to stakeholders, members of Congress and the media. Carpenter started her career on Capitol Hill on the legislative and campaign staffs of Senator Lincoln Chafee (RI).
Elizabeth Carpenter headshot
https://www.linkedin.com/in/elizabethavalere/
Executive Vice President, Policy and Research
Bayh-Dole: The fuel for America’s innovation engine
ICYMI: Biopharmaceutical companies in America hit new investment milestone
World Sickle Cell Day: Recognizing the promise of gene therapy
America's cancer research progress is real and worth protecting
Women’s Health Month: A conversation with Astellas
Research and Development
Women’s Health Month: A conversation with Astellas
Women’s Health Month: A conversation with Astellas